How to measure caries risk

By measuring oxidized HDL levels in a blood sample using a transition metal compound and acidic buffer, the method addresses the need for dental checkups in caries risk assessment, offering a reliable blood-based approach to quantify caries risk through the abundance of caries-causing bacteria.

JP7581119B2Active Publication Date: 2024-11-12SUNSTAR INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2021077833
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-04-30
Publication Date
2024-11-12
Estimated Expiration
2041-04-30

AI Technical Summary

Technical Problem

Current methods for assessing caries risk often require dental checkups and are inadequate for detecting plaque that may be temporarily removed, necessitating a method to measure caries risk without a dental examination.

Method used

Measuring the reflected value of oxidized HDL in a blood sample using a method that includes mixing a blood sample with a transition metal compound and an acidic buffer, followed by measuring free radicals produced, which correlates with the abundance ratio of caries-causing bacteria in saliva.

Benefits of technology

Enables the assessment of caries risk without a dental checkup by quantifying the abundance of Streptococcus mutans and the decrease of Streptococcus oralis in saliva, providing a reliable indicator for caries risk through blood tests.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581119000002
    Figure 0007581119000002
  • Figure 0007581119000003
    Figure 0007581119000003
  • Figure 0007581119000004
    Figure 0007581119000004
Patent Text Reader

Abstract

To provide a method of measuring caries risk.SOLUTION: A method of measuring caries risk of a subject who provided a blood sample using a reflection value of the oxidized HDL level as an indicator is provided, the method comprising measuring the reflection value of the oxidized HDL level in the blood sample.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to methods for measuring caries risk, etc. [Background technology]

[0002] It is believed that the risk of dental caries is high when plaque, a mass of bacteria, adheres to the tooth surface. Currently, the mainstream method of checking for the presence or absence of plaque is to have an oral examination by a dentist or other professional.

[0003] In addition, for example, if a person neglects their regular tooth brushing but brushes their teeth carefully just before an oral examination, the plaque removal situation will be good at the time of the examination, so there is a need for the development of a method that can appropriately evaluate the risk of dental caries. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Patent No. 6779776 Summary of the Invention [Problem to be solved by the invention]

[0005] An object of the present disclosure is to provide a method for measuring caries risk. Another object of the present disclosure is to provide a method for measuring caries risk without a dental checkup. [Means for solving the problem]

[0006] The inventors discovered that when the value reflecting the amount of oxidized HDL in a blood sample is high, the presence of Streptococcus mutans, a type of bacteria that causes dental caries, is higher in saliva compared to when the value is low, and they have made further improvements.

[0007] The present disclosure includes, for example, the subject matter described in the following sections: Section 1. A method for measuring the caries risk of a subject from whom a blood sample was taken, comprising measuring a value reflective of the amount of oxidized HDL in the blood sample, and using the value reflective of the amount of oxidized HDL as an index. Section 2. The measurement of the reflected value of the oxidized HDL amount (1) The method is carried out by a method including a step of mixing a blood sample with a solution containing a transition metal compound and an acidic buffer solution, The method according to item 1. Section 3. The measurement of the reflected value of the oxidized HDL amount moreover, (2) The method is carried out by a method including a step of measuring the free radicals produced in the step (1), The method according to item 2. Section 4. Item 4. The method according to any one of Items 1 to 3, wherein the reflection value of the oxidized HDL amount is a change in absorbance per unit time. Effect of the Invention

[0008] A method for determining caries risk is provided. Also provided is a method for determining caries risk without a dental examination. [Brief description of the drawings]

[0009] [Figure 1] FIG. 1 is a diagram showing tooth numbers and names. [Diagram 2] The figure shows the abundance ratio of Streptococcus mutans in groups with low, middle, and high values ​​reflecting the amount of oxidized HDL in blood samples. [Diagram 3] The abundance ratio of Streptococcus oralis in groups whose blood samples were reflected by low, middle, and high levels of oxidized HDL is shown. [Figure 4] The figure shows the abundance ratio of Streptococcus mutans in groups with and without PlI, in which the reflection value of the oxidized HDL amount in the blood sample was low, middle, and high. [Diagram 5]The abundance ratio of Streptococcus oralis in the low, middle, and high groups reflecting the amount of oxidized HDL in blood samples with and without PlI is shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] Each embodiment included in the present disclosure will be described in further detail below. The present disclosure encompasses a method for measuring the oral hygiene status of a subject. In this specification, the method may be referred to as the "measurement method of the present disclosure."

[0011] The measurement method of the present disclosure involves measuring a value reflective of the amount of oxidized HDL in a blood sample.

[0012] The subject may be a human or a non-human mammal. The human may be, for example, a healthy person, a human suffering from periodontal disease (a periodontal disease patient), or a human suspected of suffering from periodontal disease. The subject may be a human with HbA1c less than 5.6%, a human with fasting blood glucose less than 110 mg / dL, a human with BMI less than 30, or a human with two or more of these characteristics. The subject may be a subject with plaque in the oral cavity, or a subject without plaque in the oral cavity. The non-human mammal is not particularly limited, and examples thereof include mammals kept as pets, livestock, laboratory animals, etc. Examples thereof include dogs, cats, monkeys, cows, horses, sheep, goats, pigs, rabbits, mice, rats, camels, llamas, etc.

[0013] As used herein, "plaque" refers to a mass of bacteria that adheres to the surface of teeth. Plaque is also sometimes called dental plaque.

[0014] The method for confirming the presence or absence of plaque adhesion is not particularly limited, and any known method can be used. For example, there are a method for determining the presence or absence of plaque adhesion by scraping the tooth surface with the tip of a periodontal probe or a dental probe, a method for determining the presence or absence of plaque adhesion by staining the tooth surface using a plaque staining solution, a method for determining the presence or absence of plaque adhesion by image diagnosis, a method for detecting plaque by a sensor, etc.

[0015] The teeth to be checked for the presence or absence of plaque may be, for example, all teeth or target teeth. The target teeth may be, for example, six teeth in total, including six upper right, one upper right, six upper left, six lower right, one lower left, and six lower left. The numbers correspond to those shown in FIG. 1.

[0016] The blood sample is not particularly limited as long as it is a sample derived from blood collected from a subject, and may be, for example, whole blood or a blood separation product (e.g., serum, plasma, etc.). The method and conditions for storing the blood sample collected from the subject are not particularly limited, and may be carried out according to a conventional method.

[0017] The method for collecting a blood sample from a subject is not particularly limited and may be performed according to a conventional method. When serum or plasma is used as a blood sample, it is preferable to use a vacuum blood collection tube containing a serum or plasma separator from the viewpoints of ease of handling, prevention of infection, etc. The collected blood sample may be used as is, or may be freeze-dried or otherwise stored and then the freeze-dried product may be dissolved in a suitable solvent as described below and then used. The collected blood sample may be frozen and stored as is, or may be frozen and stored after being dissolved in a suitable solvent as described below and then thawed when ready for use.

[0018] The value reflecting the amount of oxidized HDL refers to a value reflecting the amount of oxidized HDL contained in a blood sample, and examples thereof include the weight (mass) and concentration of oxidized HDL. Alternatively, for example, a measured value reflecting the amount of oxidized HDL contained in a blood sample may be used, and examples of such values ​​include absorbance and fluorescence intensity. The measured value may be a value measured using a measurement auxiliary reagent. Examples of such measurement auxiliary reagents include fluorescent dyes, oxidized HDL-specific recognition molecules (e.g., antibodies or fragments thereof), and combinations of two or more of these.

[0019] The method for measuring the reflected value of the amount of oxidized HDL in a blood sample is not particularly limited, and can be performed according to a conventional method. For example, a method for measuring oxidized HDL (malondialdehyde-modified HDL) using an ELISA method, a method for measuring the nitration or chlorination of Apo-A1, a protein constituting HDL, using a mass spectrometer, and a method including (1) a step of mixing a blood sample with a solution containing a transition metal compound and an acidic buffer solution, as described in Japanese Patent No. 6779776 (Patent Document 1), are included. Among them, it is preferable to measure by a method including (1) a step of mixing a blood sample with a solution containing a transition metal compound and an acidic buffer solution. In this specification, this step may be referred to as "step (1)". Furthermore, it is more preferable to measure by a method including (2) a step of measuring the free radicals produced by the step (1). In this specification, this step may be referred to as "step (2)".

[0020] The method for measuring the reflective value of the amount of oxidized HDL in a blood sample may include a step of separating HDL from the blood sample. In the present specification, this step may be referred to as "step (0)". The HDL separated in step (0) can be used as the blood sample in step (1). The method for separating HDL from a blood sample is not particularly limited, and can be performed according to a conventional method. For example, the dextran sulfate method using dextran sulfate and magnesium ions can be mentioned.

[0021] The transition metal compound is not particularly limited as long as it can be ionized in the mixed solution to become a metal ion and can react with hydroxyperoxide (R-OOH) to generate a free radical, and examples thereof include copper (II) compounds, iron (II) compounds (divalent iron compounds), and iron (III) compounds (trivalent iron compounds). Among these, iron compounds such as iron (II) compounds and iron (III) compounds are preferred. Examples of iron compounds include ammonium iron (II) sulfate hexahydrate and iron (III) chloride hexahydrate. By using a transition metal compound in step (1), advantageous effects such as 1) the presence of a sufficient amount of transition metal ions that react with hydroxyperoxide makes it possible to measure oxidized HDL with a small amount of blood sample and 2) the measurement of oxidized HDL can be achieved without being affected by the amount of iron contained in blood are achieved.

[0022] In addition, the reflected value of the amount of oxidized HDL is larger in a solution containing a divalent iron compound than in a solution containing a trivalent iron compound. In other words, a measurement method using a divalent iron compound can measure oxidized HDL with higher sensitivity than a trivalent iron compound. Therefore, among the above-mentioned iron compounds, a divalent iron compound is particularly preferred.

[0023] The concentration of the transition metal compound in the mixed solution is not particularly limited, and can be, for example, about 0.1 to 150 μM, preferably 1 to 100 μM.

[0024] The acidic buffer solution is not particularly limited as long as it has an acidic pH and a buffering effect, and any known buffer solution can be used, such as an acetate buffer solution.

[0025] The pH of the acidic buffer solution is not particularly limited as long as it is acidic, and is preferably about 2 to 6.9, more preferably about 3 to 6.5, and even more preferably 4.5 to 6. When a color development method is used as a method for measuring free radicals in step (2) described below, the pH of the acidic buffer solution is particularly preferably about 3 to 6.9.

[0026] The concentration of the acidic buffer solution is not particularly limited and is, for example, 0.005 to 0.5M, preferably 0.01 to 0.2M.

[0027] The reaction temperature in step (1) is not particularly limited and can be, for example, about 20 to 40°C.

[0028] As described above, in step (1), hydroperoxides (R-OOH) in oxidized HDL contained in a blood sample react with transition metal ions to generate peroxy radicals (R-OO · ) and alkoxy radicals (RO · By measuring the free radicals produced in step (1), oxidized HDL can be measured.

[0029] Therefore, it is preferable that the method for measuring a value reflecting the amount of oxidized HDL further comprises the step (2) of measuring the free radicals produced in the above step (1).

[0030] The method for measuring free radicals is not particularly limited, and any known method can be used, such as a color development method, a chemiluminescence method, or an electron spin resonance (ESR) method.

[0031] The color-developing method uses a substance that reacts with free radicals to produce color (a color-developing substance), and measures the absorbance of the colored substance using a spectrophotometer or the like.

[0032] The color-forming substance is not particularly limited as long as it is a compound that reacts with a free radical or an alkoxy radical to develop color, and any known compound can be used. For example, a compound represented by the following general formula (1) or a salt thereof can be used.

[0033] [ka]

[0034] In the above general formula (1), each R is the same or different and represents a hydrogen atom, a halogen atom, methyl, or ethyl. In particular, it is preferable that at least two of each R are methyl or ethyl, and it is more preferable that R substituting the same nitrogen atom are both methyl or ethyl.

[0035] As the compound represented by the general formula (1), N,N-dimethyl-p-phenylenediamine (DMPD) and N,N-diethyl-p-phenylenediamine (DPD) are preferred.

[0036] Examples of the salt of the compound represented by the general formula (1) include sulfates, oxalates, and diacetates.

[0037] The compound represented by formula (1) or a salt thereof used in the reaction step may be used alone or in combination of two or more.

[0038] In addition, the compound represented by the general formula (1) can be used by dissolving it in a solvent as necessary. The solvent is not particularly limited, and examples thereof include pure water, a buffer solution, and dimethyl sulfoxide (DMSO). The concentration of the solution is not particularly limited, and can be, for example, about 0.1 to 50 mM, and preferably about 1 to 20 mM.

[0039] The method for measuring the absorbance of the colored substance is not particularly limited, and can be performed by a conventional method. For example, since a radical cation that exhibits a reddish purple color is generated by the reaction of a free radical with a color-forming substance, the radical cation can be measured by measuring the absorbance using a known device. The wavelength for measuring the absorbance can be, for example, 460 to 570 nm, preferably 500 to 560 nm.

[0040] In addition, when measuring absorbance, it is preferable to measure the time course of absorbance between the start time and the end time of measurement in order to measure quantitatively. For example, the rate of increase in absorbance (change in absorbance per unit time) may be measured with the start point being 3 minutes after the start of the reaction between the free radical and the color-developing substance and the end point being 6 minutes after the start of the reaction.

[0041] The chemiluminescence method uses a substance (luminescent substance) that reacts with free radicals to emit light, and measures the light emitted when the excited substance returns to its ground state using a luminescence spectrometer or other device.

[0042] The luminescent substance is not particularly limited as long as it is a compound that reacts with free radicals to emit light, and known compounds can be used, such as luminol, Dansyl-TEMPO, lucigenin, 2-methyl-6-p-methoxyphenylethynylimidazopyrazinone (MPEC), hydroxyphenyl fluorescein (HPF), aminophenyl fluorescein (APF), and Cypridina luciferin derivative (MCLA).

[0043] The method for measuring the light emitted by the luminescent substance is not particularly limited, and can be appropriately determined depending on the type of the luminescent substance used, etc.

[0044] The electron spin resonance method (ESR method) is a spectroscopic analysis that observes the transition between levels that occurs when an unpaired electron is placed in a magnetic field. The electron spin resonance method is not particularly limited and can be performed using a known method and device, and may be either a direct method in which free radicals are directly measured or an indirect method in which a spin trapping agent is reacted with a free radical. When an indirect method is adopted, the spin trapping agent is not particularly limited and a known spin trapping agent can be used. Examples of the spin trapping agent include nitrone-based spin trapping agents such as 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), 2,5,5-triethyl-1-pyrroline-N-oxide (M3PO), 3,3,5,5-tetramethyl-1-pyrroline-N-oxide (TMPO), and N-tert-α-phenylnitrone (PBN); and nitroso-based spin trapping agents such as 2-methyl-2-nitrosopropane (MNP) and nitrosodurene (ND).

[0045] As shown in the examples below, when the reflected value of the amount of oxidized HDL in a blood sample is high, the ratio of Streptococcus mutans, an oral bacterium that causes plaque formation and demineralization and is one of the bacteria that cause dental caries, in saliva is high, and the ratio of Streptococcus oralis, an oral bacterium that has a negative correlation with DMFT (DMFT indicates the total number of teeth that have experienced dental caries in some form, and means "D" (decayed): untreated dental caries, "M" (missing): extracted due to dental caries, and "F" (filled): teeth that have been treated due to dental caries) is low, so that the risk of dental caries is considered to be high. Therefore, according to the measurement method disclosed herein, by measuring the reflected value of the amount of oxidized HDL in a blood sample, the reflected value of the amount of oxidized HDL can be used as an index to measure the caries risk of the subject from whom the blood sample was taken.

[0046] As shown in the examples below, when the reflected value of the amount of oxidized HDL in a blood sample is high, the abundance ratio of Streptococcus mutans, an oral bacterium that causes plaque formation and demineralization and is one of the bacteria that cause dental caries, is high in saliva, regardless of the presence or absence of plaque, and the abundance ratio of Streptococcus oralis, an oral bacterium that has a negative correlation with DMFT, is low. Therefore, according to the measurement method disclosed herein, by measuring the reflected value of the amount of oxidized HDL in a blood sample, the caries risk of the subject from whom the blood sample was taken can be measured using the reflected value of the amount of oxidized HDL as an index, regardless of the presence or absence of plaque.

[0047] As used herein, caries risk refers to the likelihood of developing caries.

[0048] The risk of dental caries is thought to increase, for example, when the abundance ratio of Streptococcus mutans in saliva increases. According to the present disclosure, the abundance ratio of Streptococcus mutans in saliva can be measured (predicted) by measuring the reflected value of the amount of oxidized HDL in a blood sample. In addition, the risk of dental caries is thought to increase, for example, when the abundance ratio of Streptococcus oralis in saliva decreases. According to the present disclosure, the abundance ratio of Streptococcus oralis in saliva can be measured (predicted) by measuring the reflected value of the amount of oxidized HDL in a blood sample.

[0049] According to the measurement method of the present disclosure, for example, when the value reflecting the amount of oxidized HDL in a blood sample taken from a subject is equal to or higher than a standard value, it is possible to predict (determine) that the risk of dental caries is high, compared to when the value is below the standard value. According to the measurement method of the present disclosure, for example, when the reflected value of the oxidized HDL amount in a blood sample taken from a subject is equal to or higher than a standard value, it is possible to predict (determine) that the abundance ratio of Streptococcus mutans in saliva is high compared to when the reflected value is below the standard value.

[0050] The reference value to be compared with the reflected value of the amount of oxidized HDL in the blood sample collected from the subject can be, for example, 32.5 mOD / min or the like as the rate of increase in absorbance (change in absorbance per unit time) with the starting point being 3 minutes after the start of the reaction between the free radical and the chromogenic substance and the end point being 6 minutes after the start of the reaction. In the examples described below, the reference value indicates the 75th percentile value of the subject, and it has been confirmed that the abundance ratio of Streptococcus mutans is high and the abundance ratio of Streptococcus oralis is low at this value as the boundary.

[0051] In addition, the reference value to be compared with the reflected value of the oxidized HDL amount of the blood sample collected from the subject can be, for example, a reflected value of the oxidized HDL amount of the blood sample collected from a subject with a low caries risk, more specifically, a subject whose saliva does not contain Streptococcus mutans (for example, below the lower limit of detection). The value may be standardized based on previously obtained data.

[0052] In addition, the standard value to be compared with the value reflecting the oxidized HDL amount in a blood sample collected from a subject can be, for example, the average value, median value, 25th percentile value, 75th percentile value, mode value, etc. of the values ​​reflecting the oxidized HDL amount in blood samples in a group consisting of multiple subjects.

[0053] In addition, the measurement method of the present disclosure can also measure the change in caries risk over time in the same subject. For example, if the reflected value of the amount of oxidized HDL in the blood sample collected from the subject increases over time, it can be predicted (determined) that the caries risk may have increased. For example, if the reflected value of the amount of oxidized HDL in the blood sample collected from the subject decreases over time, it can be predicted (determined) that the caries risk may have decreased.

[0054] According to the measurement method disclosed herein, by measuring a value reflecting the amount of oxidized HDL in a blood sample, it is possible to measure caries risk, for example, based on the results of a blood test in a health checkup, even when a dental professional is not present or a dental checkup has not been conducted.

[0055] The present disclosure also encompasses a method for assisting in determining a subject's caries risk. In this specification, the method may be referred to as the "assisting method of the present disclosure."

[0056] The auxiliary method of the present disclosure involves measuring a reflective value of oxidized HDL content in a blood sample.

[0057] With regard to the reflected value of the oxidized HDL amount in the blood sample, the description of the above-mentioned "measurement method of the present disclosure" can be cited.

[0058] The assistance method of the present disclosure can assist in determining a subject's caries risk.

[0059] In addition, in this specification, the term "comprising" includes "consisting essentially of" and "consisting of." In addition, the present disclosure includes all of the constituent elements described in this specification in any combination.

[0060] In addition, the various characteristics (properties, structures, functions, etc.) described in each embodiment of the present disclosure above may be combined in any way to specify the subject matter included in the present disclosure. In other words, the present disclosure includes all subject matter consisting of all combinations of each combinable characteristic described in this specification. EXAMPLES

[0061] The contents of the present disclosure will be specifically explained using the following test examples. However, the present disclosure is in no way limited to these. In the following, unless otherwise specified, the experiments were performed under atmospheric pressure and room temperature conditions.

[0062] subject The study involved 159 men (mean age 52.0 years, standard deviation 6.4), excluding those with HbA1c of 5.6% or higher, fasting blood glucose of 110 mg / dL or higher, or BMI of 30 or higher.

[0063] Test Example 1 Calculation of the value reflecting the amount of oxidized HDL (oxHDL) in blood samples (1) Preparation of blood samples Blood was collected from the subject's vein using a vacuum blood collection tube, left at room temperature for 1 hour, and then centrifuged under general serum separation conditions to obtain the supernatant (serum) as a blood sample, which was then stored at -80°C.

[0064] (2) Measurement of oxidized HDL (oxHDL) levels A mixture of 0.1M acetate buffer (pH 4.8) and 100μM ammonium iron(II) sulfate hexahydrate was added to each well of the microplate and kept at 37℃. Next, N,N-diethyl-p-phenylenediamine sulfate solution (solvent: DMSO) was added to each well, and then the serum obtained in (1) above was added. The absorbance at a wavelength of 505nm was measured using a microplate reader (manufactured by Bio-Rad) set at 37℃. The absorbance was measured by setting the instrument to Kinetics, measuring 48 times (8 minutes in total) every 10 seconds, and calculating the absorbance change per unit time (unit: mOD / min) from each value 3 minutes to 6 minutes after the start of the measurement.

[0065] The mean oxHDL of the subjects was 30.6 mOD / min with a standard deviation of 4.7.

[0066] Test Example 2: Salivary bacterial flora analysis DNA was extracted from the subjects' saliva, and the 16S rRNA gene carried by the bacteria was amplified by PCR. Bacterial flora analysis was then performed using a next-generation sequencer, MiSeq (Illumina Inc.). The abundance ratio of two species, Streptococcus mutans and Streptococcus oralis, was analyzed.

[0067] Test Example 3 Measurement of PlI (Plaque Index) PlI was measured for six representative teeth per person (Figure 1). The representative teeth were the upper right 6, upper right 1, upper left 6, lower right 6, lower left 1, and lower left 6. However, if tooth 6 was missing, tooth 7 was used for measurement. PlI is an index showing the degree of plaque adhesion. PlI was measured for six representative teeth according to the following criteria. <Standards> 0: No adhesion observed 1: Plaque adhesion on less than 1 / 3 of the tooth surface 2: Plaque adhesion on 1 / 3 to less than 2 / 3 of the tooth surface 3: Plaque adhesion on more than 2 / 3 of the tooth surface Regarding the PlI of the six representative teeth, if the maximum PlI value was 0, it was judged as "no PlI," and if the maximum PlI value was 1 or greater, it was judged as "with PlI."

[0068] The results of plotting the presence of bacteria in each group are shown in Figure 2 (S. mutans) and Figure 3 (S. oralis), where oxHDL is defined as "low" when it is below the 25th percentile, "high" when it is above the 75th percentile, and "middle" when it is greater than the 25th percentile and less than the 75th percentile. The vertical axis shows the value obtained by converting the bacterial presence ratio into a centered logarithmic ratio and setting negative values ​​to zero. In Figures 2 and 3, the tips of the whiskers extending upward from the columns show the maximum value or the value obtained by multiplying the interquartile range by 1.5 and adding it to the 75th percentile value, the top of the column shows the 75th percentile value, the horizontal line in the column shows the 50th percentile value (median), the bottom of the column shows the 25th percentile value, and the tips of the whiskers extending downward from the columns show the minimum value or the value obtained by multiplying the interquartile range by 1.5 and subtracting it from the 25th percentile value.

[0069] As shown in Figure 2, it was confirmed that the higher the oxHDL, the higher the abundance ratio of S. mutans. Also, as shown in Figure 3, it was confirmed that the higher the oxHDL, the lower the abundance ratio of S. oralis. From this, it was found that when oxHDL is high, the risk of dental caries is high. In other words, it was suggested that the risk of dental caries can be measured by oxHDL. Note that this data was the result of an analysis conducted on only male subjects, but similar results were obtained when the analysis was conducted including female subjects.

[0070] The subjects were classified into a group with or without PlI, and the oxHDL was defined as "low" when it was below the 25th percentile, "high" when it was above the 75th percentile, and "middle" when it was above the 25th percentile but below the 75th percentile. The results of plotting the abundance ratio of bacteria in each group are shown in Figure 4 (S. mutans) and Figure 5 (S. oralis). The vertical axis shows the value obtained by converting the abundance ratio of bacteria into a centered logarithm ratio and setting negative values ​​to zero. In Figures 4 and 5, the tips of the whiskers extending upward from the columns indicate the maximum value or the interquartile range multiplied by 1.5 and added to the 75th percentile value, the top of the column indicates the 75th percentile value, the horizontal line in the column indicates the 50th percentile value (median), the bottom of the column indicates the 25th percentile value, and the tips of the whiskers extending downward from the columns indicate the minimum value or the interquartile range multiplied by 1.5 and subtracted from the 25th percentile value.

[0071] As shown in Figure 4, it was confirmed that the higher the oxHDL, the higher the abundance ratio of S. mutans, regardless of the presence or absence of plaque. Also, as shown in Figure 5, it was confirmed that the higher the oxHDL, the lower the abundance ratio of S. oralis, regardless of the presence or absence of plaque. From this, it was found that when oxHDL is high, the risk of dental caries is high, regardless of the presence or absence of plaque. Note that this data is the result of an analysis conducted on only male subjects, but similar results were obtained when the analysis was conducted including female subjects.

Claims

1. A method for measuring a caries risk of a subject from whom a blood sample was taken, comprising measuring a value reflective of the amount of oxidized HDL in the blood sample, and using the value reflective of the amount of oxidized HDL as an index.

2. The measurement of the reflection value of the amount of oxidized HDL (1) The method is carried out by a method including a step of mixing a blood sample with a solution containing a transition metal compound and an acidic buffer solution, The method of claim 1.

3. The measurement of the reflection value of the amount of oxidized HDL moreover, (2) The method is carried out by a method including a step of measuring the free radicals produced in the step (1). The method of claim 2.

Citation Information

Patent Citations

  • Oxide HDL measurement method and oxide HDL measurement kit

    JP2017227618A

  • Method for measuring oxidized HDL and kit for measuring oxidized HDL

    JP6779776B2

  • Method for predicting and preventing cardiovascular disease

    US20130230462A1

  • Method for selecting subject needing treatment for dyslipidemia and reagent for such selection

    WO2018079674A1